General Notices

• Notice to Extend Eligibility for Submission of NIAID K99 /R00 Pathway to Independence Award Applications (and Physician-Scientist K99/R00) due to COVIDrelated Disruptions
  (NOT-AI-20-068)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Expiration of NOT-EB-20-007 "Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)"
  (NOT-EB-20-015)
  National Institute of Biomedical Imaging and Bioengineering
  

• Notice of Expiration of NOT-EB-20-008: Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
  (NOT-EB-20-016)
  National Institute of Biomedical Imaging and Bioengineering
  

• Notice of Informational Webinar on PAR-20-213: National Institute of General Medical Sciences Predoctoral Institutional Research Training Grant (T32 - Clinical Trial Not Allowed)
  (NOT-GM-20-052)
  National Institute of General Medical Sciences
  

• Notice of Pre-Application Webinars for the NHGRI Genomic Innovator Award
  (NOT-HG-20-053)
  National Human Genome Research Institute
  

• Notice of Pre-Application Webinars for the Impact of Genomic Variation on Function (IGVF) Consortium FOAs (RFA-HG-20-043, RFA-HG-20-044, RFA-HG-20-045, RFA-HG-20-046, RFA-HG-20-047)
  (NOT-HG-20-055)
  National Human Genome Research Institute
  

• Findings of Research Misconduct
  (NOT-OD-20-165)
  National Institutes of Health
  

• Findings of Research Misconduct
  (NOT-OD-20-166)
  National Institutes of Health
  

• Request for Information (RFI): Information and Data Resources Needed by the Health Services Research Community for Research and Practice.
  (NOT-LM-20-017)
  National Library of Medicine
  

Notice of Changes to Funding Opportunities

• Notice of Participation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in PAR-19-064: Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
  (NOT-AA-20-020)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Change to RFA-AG-21-003 New/Unconventional Animal Models of Alzheimers Disease (R24 Clinical Trial Not Allowed)
  (NOT-AG-20-047)
  National Institute on Aging
  

• Notice of Temporary Extension of Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00)
  (NOT-DE-20-031)
  National Institute of Dental and Craniofacial Research
  

• Notice of Revision to Funding Opportunity Description for RFA-DK-20-017: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Field Epidemiology Sites (U01 - Clinical Trial Not Allowed)
  (NOT-DK-20-041)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Revision to Funding Opportunity Description for RFA-DK-20-018, Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium Renal Science Core (U01 - Clinical Trial Not Allowed)
  (NOT-DK-20-042)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Revision to Funding Opportunity Description for RFA-DK-20-019, Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Scientific Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (NOT-DK-20-043)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of NHLBI Participation in PAR-18-901 "Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)"
  (NOT-HL-20-807)
  National Heart, Lung, and Blood Institute
  

• Notice of NHLBI Participation in PAR-19-098 "Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)"
  (NOT-HL-20-808)
  National Heart, Lung, and Blood Institute
  

• Notice of Change in Application Due Date for RFA-HL-21-013 "Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)"
  (NOT-HL-20-811)
  National Heart, Lung, and Blood Institute
  

• Notice of NLM Participation in PAR-20-150 "NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)"
  (NOT-LM-20-016)
  National Library of Medicine
  

• Notice of NIMHD Withdrawal from Participation in PA-20-195 and PA-20-196: NIH Exploratory/Developmental Research Grant Programs (Parent R21 Clinical Trial Not Allowed) and (Parent R21 Basic Experimental Studies with Humans Required)
  (NOT-MD-20-027)
  National Institute on Minority Health and Health Disparities
  

• Notice of Change to Key Dates for RFA-NS-18-021 "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Required)"
  (NOT-NS-20-103)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to Key Dates for RFA-NS-18-022 "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44 Clinical Trial Required)"
  (NOT-NS-20-104)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to Key Dates for RFA-NS-18-023 "BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Required)"
  (NOT-NS-20-105)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Participation in RFA-OD-20-023, "Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)"
  (NOT-TR-20-034)
  National Center for Advancing Translational Sciences
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)
  (NOT-CA-20-095)
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  

• Notice of Intent to Publish a HEAL Funding Opportunity Announcement for Consortium on Co-managing Chronic Pain and Opioid Use Disorder (C3PO) (RM1)
  (NOT-DA-20-071)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Intent to Publish a HEAL Funding Opportunity Announcement for Research on Related DSM-5 Diagnoses (R2D2) Coordination and Dissemination Center
  (NOT-DA-20-077)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Intent to Publish Funding Opportunity Announcements for Music and Health: Understanding And Developing Music Medicine (R01)
  (NOT-NS-20-096)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Music and Health: Understanding And Developing Music Medicine (R21)
  (NOT-NS-20-100)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute of Biomedical Imaging and Bioengineering
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  

Notices of Special Interest

• Notice of Special Interest: Alcohol and Aging
  (NOT-AA-20-019)
  National Institute on Alcohol Abuse and Alcoholism
  

• RESCINDED - Notice of Special Interest: Administrative Supplements to Support Emerging Physician-Scientists to Develop Research Expertise in Diabetes, Endocrinology and Metabolic Diseases
  (NOT-DK-20-040)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

Funding Opportunities

• Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support
  (PA-20-074)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Standard dates apply The first standard due date for the FOA is January 25, 2021. All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Research to Improve Native American Health (R21 Clinical Trials Optional)
  (PAR-20-214)
  National Institute on Drug Abuse
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): May 17, 2021; May 17, 2022; May 17, 2023
  
  

• Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
  (PAR-20-238)
  National Institute on Drug Abuse
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): ?May 17, 2021, May 17, 2022, May 17, 2023
  
  

• NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed).
  (PAR-20-283)
  National Library of Medicine
  Office of Research on Women's Health
  Application Receipt Date(s): October 23, 2020, October 22, 2021, October 21, 2022
  
  

• Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33 Clinical Trial Not Allowed)
  (RFA-CA-20-044)
  National Cancer Institute
  Application Receipt Date(s): October 30, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
  
  

• NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional)
  (RFA-HD-21-023)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below. All applications are due by 5:00 PM local time of applicant organization.